DE3868986D1 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number: DE3868986D1
Authority: DE; Germany
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1987-05-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE8888304008T

Other languages

English (en)

Inventor

Gordon France Gordon France

Graham Stanley Leonard Leonard

Edward Pearmain

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Smith Kline and French Laboratories Ltd

GlaxoSmithKline LLC

Original Assignee

Smith Kline and French Laboratories Ltd

GlaxoSmithKline LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-05-08

Filing date

1988-05-04

Publication date

1992-04-16

1988-05-04 Application filed by Smith Kline and French Laboratories Ltd, GlaxoSmithKline LLC filed Critical Smith Kline and French Laboratories Ltd

1992-04-16 Application granted granted Critical

1992-04-16 Publication of DE3868986D1 publication Critical patent/DE3868986D1/de

2008-05-05 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DE8888304008T 1987-05-08 1988-05-04 Pharmazeutische zusammensetzungen. Expired - Lifetime DE3868986D1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB878710965A GB8710965D0 (en)	1987-05-08	1987-05-08	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
DE3868986D1 true DE3868986D1 (de)	1992-04-16

Family

ID=10617055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE8888304008T Expired - Lifetime DE3868986D1 (de)	1987-05-08	1988-05-04	Pharmazeutische zusammensetzungen.

Country Status (13)

Country	Link
US (1)	US5169640A (de)
JP (1)	JPH0645540B2 (de)
KR (1)	KR890701102A (de)
AU (1)	AU602583B2 (de)
CA (1)	CA1304685C (de)
DE (1)	DE3868986D1 (de)
ES (1)	ES2032963T3 (de)
GB (1)	GB8710965D0 (de)
GR (1)	GR3004356T3 (de)
IE (1)	IE60948B1 (de)
PT (1)	PT87422B (de)
WO (1)	WO1988008704A2 (de)
ZA (2)	ZA883167B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5286489A (en) *	1985-08-26	1994-02-15	The Procter & Gamble Company	Taste masking compositions
KR960011236B1 (ko) *	1987-05-08	1996-08-21	스미스 클라인 앤드 프렌취 라보라토리스 리미티드	제약학적 조성물 및 고체 제형
GB9127150D0 (en) *	1991-12-20	1992-02-19	Smithkline Beecham Plc	Novel treatment
GR1002332B (el) *	1992-05-21	1996-05-16	Mcneil-Ppc Inc.	Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5622980A (en) *	1993-08-17	1997-04-22	Applied Analytical Industries, Inc.	Oral compositions of H2-antagonists
US6676967B1 (en)	1993-09-20	2004-01-13	Kos Pharmaceuticals, Inc.	Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6080428A (en)	1993-09-20	2000-06-27	Bova; David J.	Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6818229B1 (en)	1993-09-20	2004-11-16	Kos Pharmaceuticals, Inc.	Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en)	1993-09-20	2000-10-10	Bova; David J.	Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6746691B2 (en)	1993-09-20	2004-06-08	Kos Pharmaceuticals, Inc.	Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US5399356A (en) *	1994-03-24	1995-03-21	The Procter & Gamble Company	Process for making solid dose forms containing bismuth
DE19529862A1 (de) *	1995-08-14	1997-02-20	Rhone Poulenc Rorer Gmbh	Pharmazeutische, oral anwendbare Zubereitung
US6391338B1 (en) *	1995-09-07	2002-05-21	Biovail Technologies Ltd.	System for rendering substantially non-dissoluble bio-affecting agents bio-available
TW469135B (en) *	1995-10-03	2001-12-21	Chugai Pharmaceutical Co Ltd	Chewable tablet
US8071128B2 (en)	1996-06-14	2011-12-06	Kyowa Hakko Kirin Co., Ltd.	Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE69739967D1 (de) *	1996-06-14	2010-09-30	Kyowa Hakko Kirin Co Ltd	Eine im Mund schnell zerfallende Tablette
JP3001440B2 (ja) *	1996-11-25	2000-01-24	日本電気通信システム株式会社	仮想ｌａｎ方式
US6890524B1 (en)	1997-04-04	2005-05-10	Monsanto Company	Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
AU6783498A (en)	1997-04-04	1998-10-30	Monsanto Company	Ph-selective delivery system using cross-linked polymeric resins as vehicles
US6096834A (en) *	1997-04-04	2000-08-01	Monsanto Company	Hydrolyzable delivery system using crosslinked polymeric resins as vehicles
US5939091A (en) *	1997-05-20	1999-08-17	Warner Lambert Company	Method for making fast-melt tablets
US9358214B2 (en)	2001-10-04	2016-06-07	Adare Pharmaceuticals, Inc.	Timed, sustained release systems for propranolol
US8367111B2 (en)	2002-12-31	2013-02-05	Aptalis Pharmatech, Inc.	Extended release dosage forms of propranolol hydrochloride
US8747895B2 (en)	2004-09-13	2014-06-10	Aptalis Pharmatech, Inc.	Orally disintegrating tablets of atomoxetine
US9884014B2 (en)	2004-10-12	2018-02-06	Adare Pharmaceuticals, Inc.	Taste-masked pharmaceutical compositions
NZ589750A (en)	2004-10-21	2012-07-27	Aptalis Pharmatech Inc	Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en)	2005-05-02	2015-10-20	Adare Pharmaceuticals, Inc.	Timed, pulsatile release systems
EP1965771A1 (de) *	2005-12-21	2008-09-10	ADD Advanced Drug Delivery Technologies, Ltd.	Pellets enthaltend einen kern mit einem wasserlöslichen träger
EP1983827A4 (de)	2006-02-01	2013-07-10	Stuart L Weg	Verwendung von antifungalen zusammensetzungen für die behandlung von erkrankungen des oberen magen-darm-trakts
WO2009095210A1 (en) *	2008-01-31	2009-08-06	Bayer Consumer Care Ag	Composition comprising an antacid and a h2-antagonists
ES2357209B1 (es) *	2009-05-26	2011-12-07	Fundacion Universitaria San Pablo-Ceu	Composición farmacéutica sólida a base de famotidina contra la hipersecreción gástrica y otras enfermedades relacionadas, con mayor eficacia sinérgica y más rápida actuación.
JP5309262B2 (ja)	2009-12-02	2013-10-09	アプタリスファーマリミテッド	フェキソフェナジン・マイクロカプセル及びそれを含む組成物
JP6018911B2 (ja) *	2012-12-27	2016-11-02	ライオン株式会社	顆粒剤、カプセル剤
TWI724629B (zh) *	2018-11-16	2021-04-11	日商協和化學工業股份有限公司	緩瀉用錠劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3501571A (en) *	1965-12-06	1970-03-17	Smithkline Corp	Novel silicone compositions and method of preparing same
GB1601833A (en) *	1978-02-06	1981-11-04	Wellcome Found	Antacid formulation
US4681756A (en) *	1981-04-29	1987-07-21	Hoffman-La Roche Inc.	Prevention of N-nitroso compound formation in vivo
HU187215B (en) *	1983-01-26	1985-11-28	Egyt Gyogyszervegyeszeti Gyar	Method for producing pharmaceutical product of high actor content and prolonged effect
CA1239349A (en) *	1983-10-10	1988-07-19	Eberhard F. Gottwald	Pharmaceutical composition containing cimetidine
US4676984A (en) *	1985-08-14	1987-06-30	American Home Products Corp.	Rehydratable antacid composition
KR960011236B1 (ko) *	1987-05-08	1996-08-21	스미스 클라인 앤드 프렌취 라보라토리스 리미티드	제약학적 조성물 및 고체 제형

1987
- 1987-05-08 GB GB878710965A patent/GB8710965D0/en active Pending
1988
- 1988-05-04 ZA ZA883167A patent/ZA883167B/xx unknown
- 1988-05-04 JP JP63503931A patent/JPH0645540B2/ja not_active Expired - Lifetime
- 1988-05-04 US US07/297,197 patent/US5169640A/en not_active Expired - Lifetime
- 1988-05-04 DE DE8888304008T patent/DE3868986D1/de not_active Expired - Lifetime
- 1988-05-04 KR KR1019890700008A patent/KR890701102A/ko not_active Application Discontinuation
- 1988-05-04 AU AU17141/88A patent/AU602583B2/en not_active Expired
- 1988-05-04 WO PCT/GB1988/000350 patent/WO1988008704A2/en unknown
- 1988-05-04 ES ES198888304008T patent/ES2032963T3/es not_active Expired - Lifetime
- 1988-05-05 ZA ZA883212A patent/ZA883212B/xx unknown
- 1988-05-05 PT PT87422A patent/PT87422B/pt not_active IP Right Cessation
- 1988-05-06 CA CA000566093A patent/CA1304685C/en not_active Expired - Lifetime
- 1988-05-06 IE IE136988A patent/IE60948B1/en not_active IP Right Cessation
1992
- 1992-04-15 GR GR920400719T patent/GR3004356T3/el unknown

Also Published As

Publication number	Publication date
PT87422A (pt)	1989-05-31
JPH0645540B2 (ja)	1994-06-15
PT87422B (pt)	1992-08-31
ZA883167B (en)	1990-02-28
IE881369L (en)	1988-11-08
IE60948B1 (en)	1994-09-07
WO1988008704A2 (en)	1988-11-17
ES2032963T3 (es)	1993-03-01
AU602583B2 (en)	1990-10-18
ZA883212B (en)	1989-03-29
KR890701102A (ko)	1989-12-19
AU1714188A (en)	1988-12-06
JPH02500747A (ja)	1990-03-15
CA1304685C (en)	1992-07-07
WO1988008704A3 (en)	1989-02-09
US5169640A (en)	1992-12-08
GB8710965D0 (en)	1987-06-10
GR3004356T3 (de)	1993-03-31

Legal Events

Date	Code	Title	Description
1993-04-08	8364	No opposition during term of opposition

Publication	Publication Date	Title
DE3863963D1 (de)	1991-09-05	Pharmazeutische zusammensetzungen.
DE3868986D1 (de)	1992-04-16	Pharmazeutische zusammensetzungen.
DE68901417D1 (de)	1992-06-11	Pharmazeutische zusammensetzung.
DE122004000023I2 (de)	2009-05-07	Pharmazeutische Zusammensetzung
DE68911473T2 (de)	1994-05-05	Arzneimittelformulierungen.
FI901102A0 (fi)	1990-03-05	Farmaceutiska kompositioner.
FI922364A0 (fi)	1992-05-22	Farmaceutiska kompositioner.
DE3586545D1 (de)	1992-09-24	Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
DE3486255T2 (de)	1994-03-24	Pharmazeutische Zusammensetzungen.
DE3483133D1 (de)	1990-10-11	Pharmazeutische zusammensetzungen.
DE69006094T2 (de)	1994-05-05	Pharmazeutische Zusammensetzungen.
DE69115263D1 (de)	1996-01-18	Pharmazeutische zusammensetzungen.
DE3484098D1 (de)	1991-03-14	Pharmazeutische zusammensetzungen.
IT8820386A0 (it)	1988-04-29	Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI893643A (fi)	1990-02-19	Farmaceutiska kompositioner.
DE3682083D1 (de)	1991-11-28	Pharmazeutische zusammensetzungen.
FI872733A0 (fi)	1987-06-18	Farmaceutiska kompositioner.
FI872313A (fi)	1987-11-28	Farmaceutiska kompositioner.
FI883673A0 (fi)	1988-08-05	Farmaceutiska kompositioner.
DE3674040D1 (de)	1990-10-18	Pharmazeutische zusammensetzungen.
DE3866789D1 (de)	1992-01-23	Pharmazeutische zusammensetzungen.
DE3483900D1 (de)	1991-02-14	Pharmazeutische zusammensetzungen.
DE68907609T2 (de)	1994-03-10	Arzneimittelzusammensetzung.
DE68902056T2 (de)	1992-12-03	4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
DE3768109D1 (de)	1991-04-04	Pharmazeutische zusammensetzungen.